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Abstract
Curative breast radiotherapy typically leaves patients with varying degrees of
cosmetic damage. One problem interfering with cosmetically acceptable breast
radiotherapy is the external contour for large pendulous breasts which often
results in high doses to skin folds. Thermoplastic casts are often employed to
secure the breasts to maintain setup reproducibility and limit the presence of
skin folds. This paper aims to determine changes in surface dose that can be
attributed to the use of thermoplastic immobilization casts. Skin dose for a
clinical hybrid conformal/IMRT breast plan was measured using radiochromic
film and MOSFET detectors at a range of water equivalent depths representative
of the different skin layers. The radiochromic film was used as an integrating
dosimeter, while the MOSFETs were used for real-time dosimetry to isolate
the contribution of skin dose from individual IMRT segments. Strips of film
were placed at various locations on the breast and the MOSFETs were used to
measure skin dose at 16 positions spaced along the film strips for comparison
of data. The results showed an increase in skin dose in the presence of
the immobilization cast of up to 45.7% and 62.3% of the skin dose without
the immobilization cast present as measured with Gafchromic EBT film and
MOSFETs, respectively. The increase in skin dose due to the immobilization
cast varied with the angle of beam incidence and was greatest when the beam
was normally incident on the phantom. The increase in surface dose with the
immobilization cast was greater under entrance dose conditions compared to
exit dose conditions.
(Some figures in this article are in colour only in the electronic version)
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1. Introduction
Breast radiotherapy presents a number of technical challenges to clinicians when treating large
breasted women (Pidcock and Rattray 2002). Curative breast radiotherapy typically leaves
patients with varying degrees of cosmetic damage (Fernando et al 1996, Holli et al 2002).
The amount of damage depends on many factors including breast size, shape, genetics, and
generally, what type of breast radiotherapy is employed (Fernando et al 1996). One problem
interfering with cosmetically acceptable breast radiotherapy is the external contour for large
pendulous breasts. These often result in high doses to skin folds. One approach to the
pendulous breast problem is through use of immobilization cast devices. These are typically
in the form of exoskeleton-type shells or rings placed around the breast to prevent mobility
with the patient in the supine position (Latimer et al 2005). Immobilization devices are used
extensively already for head and neck treatments, purely for the purpose of immobilization
and setup error reduction. For use with breast radiotherapy there are additional potential
advantages. The first of these being a shift in breast tissue antero-medially which could lessen
the amount of lung/heart tissue within the field. The second advantage is a reduction in skin
folds receiving high dose, and the third, a reduction in breast separation that has previously
been shown in prone therapy to improve dose homogeneity.
The primary disadvantage of using an immobilization cast is that it might provide a bolus
effect to the entire breast surface. The effect of bolus material on skin dose has been measured
in previous studies (Chiu-Tsao and Chan 2010, Hsu et al 2008, Lee et al 2002, Quach et al
2000). Lee et al (2002) showed, using thermoluminescent dosimeter (TLD) detectors, that
the surface dose for head and neck radiotherapy increased due in part to the bolus effect of
immoblization cast material which contributed to increased skin toxicity. Quach et al (2000)
measured the surface dose on a hemicylinder phantom irradiated with 6 MV photons and found
that the highest surface dose was at the apex of the hemicylinder, that is, when the beam was
tangential to the surface of the phantom. The addition of 1 cm bolus material increased the
surface dose for beam entrance locations by up to 350%; however this decreased at tangential
and beam exit locations to approximately 10%. Hsu et al (2008) measured the surface dose on
both slab and anthropomorphic phantoms for a variety of bolus materials. The authors found
that surface dose increased with more tangential beams and that surface dose increased with
bolus materials. The increase in surface dose however decreased as the beams became more
tangential. Chiu-Tsao and Chan (2010) carried out a comprehensive set of measurements of
skin doses with radiochromic film in the presence of various immobilization devices. For
6 MV photons normally incident on a slab phantom, thermoplastic mesh material resulted in a
surface dose (at 153 μm water equivalent depth (WED)) increase of 170–280%, relative to the
surface dose measured with no thermoplastic material present. The dose increase depended
on whether the point of measurement was under a hole or a strut of the mesh.
The current study aims to quantify any increase in surface dose attributed to a particular
immobilization cast. The surface dose for a hybrid conformal/IMRT breast treatment plan was
measured on an anthropomorphic phantom using radiochromic film and a MOSFET detector
specifically designed for skin dosimetry, the MOSkinTM (Kwan et al 2008).
2. Methods
2.1. Treatment plan measurements
A rigid anthropomorphic phantom was employed for dosimetry in this study. The phantom
was constructed of tissue analog material with removable breasts, such that a range of sizes
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Figure 1. Axial view of the anthropomorphic phantom with opposed tangents.
can be used for dosimetry as required. The breast size used for this study was D-size, since
pendulous breasts are roughly this size and above. With the D-sized breasts in place, the
phantom was scanned on a Siemens Sensation Open CT for radiotherapy treatment planning.
An IMRT plan was created using the P3IMRT tool in the Pinnacle treatment planning system
(v8.0, Philips Medical Systems, Fitchburg, WI, USA). The plan consisted of four fields:
an open and a modulated field from each of two opposed gantry angles (311◦ and 135◦,
IEC Convention (IEC 1996)). The goal of the IMRT optimization was to minimize hot
dose spots throughout the breast, and in general deliver as homogeneous a dose distribution
throughout the breast volume as possible. The dose distribution in a transverse slice is shown in
figure 1.
The phantom was irradiated using a Varian 2100C (Varian Medical Systems, Palo Alto,
CA, USA) linear accelerator, with the phantom positioned upon an Alpha-cradle (Smithers
Medical Products, Inc., OH, USA) in the supine position. An Orfit immobilization device
(Orfit Industries America, NY, USA) was molded to the phantom. The phantom was aligned
using room laser alignment to markers placed at the time of simulation.
2.2. Film dosimetry
Gafchromic EBT film was used (International Specialty Products, NJ, USA). The active layer
of the film is at a WED of 153 μm (Devic et al 2006) and was used to measure dose slightly
deeper than 70 μm, the ICRP-recommended average depth of the radiosensitive basal cell layer
in the skin (ICRP 1991). This dosimeter was used for its ability to obtain 2D dose maps. It is
also interesting to obtain dose measurements slightly deeper than 70 μm as the epidermal layer
of the skin can vary in thickness (ICRP 1975). The film was prepared by cutting sheets into
1.5 × 25 cm2 strips for placement on the phantom surface at points of interest. A set of calibra-
tion films were irradiated at the time of experimentation and all films scanned approximately
24 h later. This was to take into account sensitivity differences between batches of film and
eliminate the optical density dependence of readout on time after irradiation (Soares 2006).
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Figure 2. Detector locations. Black strips represent approximate film locations; white spots
indicate approximate MOSFET points.
Film was scanned using an Epson Perfection V700 (Epson America Inc., Long Beach, CA,
USA) scanner in reflective mode in the center of the field, as this improves scanner uniformity
(Kalef-Ezra and Karava 2008). Scans were performed at 16 bit per color channel and 72
dpi. Scanning at greater resolution than 72 dpi provides no great advantage (Martisikova et al
2008). Data was taken from the red channel only, as this corresponds closely to the maxima
on the absorption curve for Gafchromic films, achieving greatest scan sensitivity. All films
were used within the manufacturer specified dose range. Calibration and measurement films
were scanned in the same orientation to minimize this source of error.
Film was placed on the phantom surface in the medial to lateral direction as shown in
figure 2. The first strip of the film went from the manubrium, across isocenter, toward the
axilla. The second strip went from the apex of the contralateral breast, across the sternum,
over the apex of the ipsilateral breast, and down to the anterior/posterior simulation tattoo.
The third strip went from approximately the xiphoid, along the inframammary fold region
and down the chest wall laterally. The film outlines were drawn on the phantom to permit
accurate placements of further film as required (for each tangential beam). The points for film
dosimetry were chosen as they are reported sites of skin toxicity for breast irradiation and as
such are of clinical interest (Donovan et al 2007, Fernando et al 1996).
2.3. MOSFET dosimetry
MOSFET dosimeters were used to obtain point dose measurements at various positions of
interest also measured by the film. The MOSFET detector used for these measurements was
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the MOSkin. The MOSkin has a WED of measurement of 70 μm, the ICRP-defined depth of
the radiosensitive basal layer in the skin (ICRP 1991). A feature of the MOSkin is that it can be
read out in real time, allowing for resolution of each individual field’s contribution to the total
dose distribution. The MOSkin detector system has been used previously for skin and surface
dosimetry (Hardcastle et al 2008, Kwan et al 2008). The MOSFETs were read out in real
time using a computerized reader developed in-house (Center for Medical Radiation Physics,
University of Wollongong, Australia). Calibration of the MOSFET dosimeters was undertaken
at 100 cm source to surface distance, with the dosimeter at dmax (1.5 cm) using a 10 × 10
cm2 field. The MOSFET detector sensitivity slightly decreases, within 5%, with absorbed
dose; therefore greater accuracy in measurements can be obtained by using an average of the
calibration factors before and after particular measurements are obtained. The calibration of
the MOSFET detectors and all measurements were carried out at the same temperature to
remove the effects of temperature variation on measurements. All MOSFET measurements
were carried out three times to obtain measurement variance.
Real-time dosimetry for each of the 16 MOSFETs was performed at a frequency of 1 Hz
using a CMRP MOSFET reader. This allowed visualization, on a graphical display using
in-house-developed software, of the contribution from each open and modulated field to the
overall surface dose in real time. The sensitivity of the MOSFET depends on gate bias. The
linearity of the response and sensitivity was improved by applying a +15 V gate bias to the
MOSFET. The read-out process does not affect the final measured dose, as the gate voltage is
only inverted for 0.01% of the duty cycle; the sensitivity of the MOSFET is only affected for
0.01% of the total irradiation time.
MOSFETs were taped onto the phantom at measured intervals along the film dosimetry
positions to obtain point doses for comparison with film. The locations of the MOSFET
detectors are shown in figure 2. Care was taken to have no air gaps behind the dosimeters
and to ensure the tape was not covering the sensitive volume of the MOSFETs. The film and
MOSFET measurements were carried out in separate irradiations to prevent the interference
of one dosimeter with the other. The treatment involved two opposed fields, with multiple
segments within each field. Therefore, film and MOSFET data was taken for both gantry
angles, with and without Orfit, so that entrance and exit dose to the dosimeters could be
separated.
2.4. Effect of immobilization cast thickness on surface dose increase
The immobilization cast thickness varies with the amount the material is stretched. At regions
of high electronic disequilibrium such as at the surface, the change in thickness will have
a large effect on the measured dose. The variation of surface dose increase with the cast
thickness was measured. A MOSFET was placed on the surface of a slab phantom. Two
immobilization casts were created to cover the MOSFET. The first cast had limited stretching
and had holes of 2.2 × 1.8 mm ± 0.1 mm and was 1.5 ± 0.2 mm thick (referred to as ‘thick
Orfit’). The second cast was stretched to be thinner, with larger holes of 6.2 × 2.3 mm ± 0.1
mm and was 1.2 ± 0.1 mm thick (referred to as ‘thin Orfit’). For reference, unstretched Orfit
material is approximately 2.6 mm thick. The surface dose was measured with the MOSFET
both under cast material and under a gap in the material for both casts and without a cast.
The variation in measured surface dose with incident beam angle, from 0◦ to 85◦, was also
measured.
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(a) (b)
Figure 3. Film measurements (a) without the immobilization cast present, and (b) with the
immobilization cast present.
3. Results
3.1. Film and MOSFET measurements
Figure 3 shows the digitized film images converted into normalized dose (normalized to the
prescription dose of 2 Gy). The digitized film images have been overlaid onto their respective
locations on the phantom. The presence of the Orfit immobilization cast during irradiation
can clearly be identified in figure 3 by the presence of significant dose increases observed at
the axilla, breast apex, and inframammary fold regions. The cross-hatched pattern is a result
of the bolus effect of the cast material. This cross-hatching pattern is more evident where the
surface is more normal to the beam direction. Where the surface is more tangential to the
beam direction, a more uniform increase in dose is evident from the cast material.
Figure 4 shows the total dose distribution during the treatment measured by the film.
The profiles were obtained by taking line profiles through the central three pixels along each
film. The doses from the MOSFETs at the positions shown in figure 2 are also shown in
figure 4, with their corresponding position numbers. The MOSFET error bars represent the
95% confidence interval of the mean of three measurements using Student’s t-test. Table 1
shows the percentage increase in skin dose at each measurement location, relative to the dose
with no immobilization cast.
In figure 4(a) it is seen that the immobilization cast increased the superior in-field surface
dose by 27.3–45.7% and 28.4–62.3% as measured by the film and MOSFET dosimeters,
respectively. The MOSFET dose measurements in figure 4(a) agree within error with the
dose at corresponding film positions and follow the general trend of increased dose away from
the midline and toward the axilla in both cases with and without Orfit. Figure 4(b) shows
an increase in central in-field surface dose by 12.1–109.8% and 3.6–44.7% as measured by
the film and MOSFET dosimeters, respectively. The high increase at position 5 (109.8%)
measured with the film can be attributed to the very high dose gradient at this location which
increases the sensitivity to positional variations. The MOSFET-measured doses are slightly
less than that measured by the film. Figure 4(c) shows an increase in inferior in-field surface
dose by 14.2–23.0% and 30.0–49.4% as measured by the film and MOSFET dosimeters,
respectively. In the presence of the Orfit, the MOSFET-measured inferior dose is larger than
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(a)
(b)
(c)
Figure 4. Measured Gafchromic EBT film profiles and MOSFET point dose measurements at the
detector locations given in figure 2 for (a) superior film strip and MOSFET positions 1 through 4,
(b) central film strip and MOSFET positions 5 through 12 and (c) inferior film strip and MOSFET
positions 13 through 16.
the EBT-measured dose, despite a lower WED for the MOSFET compared with Gafchromic
EBT film. This is most probably due to error in placement of the MOSFETs possibly medio-
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Table 1. Percentage increase in surface dose due to the immobilization cast (relative to no cast) at
the 16 measurement locations shown in figure 2.
% increase in surface dose
Strip Position Gafchromic EBT film MOSFET
Superior 1 45.7 62.3
2 41.5 37.8
3 35.0 49.1
4 27.3 28.4
Central 5 109.8 3.6
6 17.3 15.7
7 13.7 14.6
8 12.1 18.1
9 25.3 25.8
10 14.2 27.2
11 39.9 31.2
12 30.2 44.7
Inferior 13 14.2 34.1
14 20.2 30.0
15 23.0 37.6
16 22.5 49.4
laterally but more likely in the superior–inferior direction where a high dose gradient exists
(figure 1) and any superior–inferior shift in measurement location would result in a large
difference in measured dose.
3.2. The effect of Orfit on entrance/exit dose
In order to understand the contributions of each gantry angle to the surface dose presented
in figure 4b, the dose components were split up into the dose delivered from the two gantry
angles. This data is presented in figure 5, with the percentage differences in surface dose
with the immobilization cast (normalized to no cast) presented in table 2. Figure 5(a) shows
the Gafchromic EBT film and MOSFET data from the 135◦ beam which delivers dose from
the lateral to medial beam direction. From approximately 30 to 46 cm is the lateral breast
wall where the dosimeters are exposed to the build-up region of this beam (entrance dose).
Below 30 cm is the apex of the breast and medial breast wall where the dosimeters are exposed
to tangential irradiation and build-down region of the beam (exit dose). In figure 5(a) the
Gafchromic EBT film results show that for the lateral wall the Orfit increases the dose (up to
79.5% for film and 78.6% for MOSFET); however for the medial wall the Orfit has minimal
effect on the dose (maximum increase of 7.8% for film and 5.4% for MOSFET).
The extra build-up material provided by the Orfit increases the surface dose in the case
where the surface dose is due to beam entrance and minimally in the case where the surface
dose is due to beam exit. In figure 5(b), which shows the surface dose due to the 311◦ beam,
the Orfit causes the largest increase in surface dose between 12.5 and 30 cm (up to 37.6%
for film and 33.4% for MOSFET, ignoring point 5 due to reasons described above) where
the beam is incident tangentially to the apex directly on the medial breast wall. The Orfit
is also seen to slightly increase the dose (up to 15.7% for film and 22.5% for MOSFET)
for the region 30–50 cm where the surface dose is due to the beam exiting the phantom. In
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(a)
(b)
Figure 5. Contribution to surface dose from individual gantry angles for the central film:
(a) surface dose from gantry angle 135◦ and (b) surface dose from gantry angle 311◦. The
addition of dose from (a) and (b) gives the total treatment dose in figure 4(b).
figure 5(b) there are two clear peaks in the dose profile. The first, occurring at approximately
14 cm, is due to tangential irradiation of the contralateral breast. The second, occurring at
approximately 30 cm, is due to tangential irradiation of the target breast. There is a point of
minimal dose between the two peaks, occurring at approximately 22.5 cm. This is where the
beam is normally incident on the breast surface, therefore the depth of measurement in the
Gafchromic EBT film is at its shallowest as seen by individual incident beamlets (surface dose
increases with increasing surface angle).
3.3. Variation of surface dose with cast thickness and incident angle
The variation of the MOSFET-measured surface dose with the cast thickness and incident beam
angle was measured. Figure 6 shows the surface dose increasing with the increase of beam
obliquity. For measurement points under the cast material, the thicker cast material resulted
in a larger increase in surface dose compared with the thinner cast material, as expected.
Under a gap in the cast material, the thicker cast material results in only very small increases
in surface dose. The presence of the cast material results in an approximately 35% to 48%
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Figure 6. Surface dose variation with the immobilization cast thickness and incident beam angle.
The error bars represent 1 standard deviation of the mean of three measurements. The dose is
normalized to cGy MU−1 where 1 MU = 1 cGy at a depth of 1.5 cm in water for a 10 × 10 cm2
6 MV photon field at 100 cm SSD.
Table 2. Percentage increases in surface dose due to the immobilization cast (relative to no cast)
along the central strip for the two beams.
% increase in surface dose
Gantry angle Position Gafchromic EBT film MOSFET
135◦ 5 13.93 −0.68
6 7.84 −2.64
7 2.84 0.00
8 0.80 5.46
9 17.70 11.72
10 15.16 33.26
11 79.53 60.54
12 48.71 78.62
311◦ 5 120.80 5.80
6 25.87 31.63
7 37.61 32.54
8 29.59 33.41
9 33.22 38.82
10 15.73 22.50
11 10.83 5.81
12 9.15 9.77
increase in surface dose for the thinner and thicker cast material, respectively, compared with
no immobilization cast at 0◦ even under a gap in the cast. This increases to 51% and 60%
increases in surface dose for the thinner and thicker cast material, respectively, at 75◦.
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4. Discussion
This study utilizes two different radiation detector systems to quantify the effect of an
immobilization cast on skin dose in breast radiotherapy. Both the Gafchromic EBT film
and MOSFET results show an increase in surface dose as a result of the bolus effect of the
cast material. The presence of Orfit stretch-holes can be clearly seen on the Gafchromic EBT
film strip in figure 3 and by the modulation in dose measured by the film. It can also be seen
that lateral scatter from the Orfit structure surrounding a stretch-hole contributes to the surface
dose in the uncovered area of skin. This is evidenced by the dose in a stretch-hole being
higher than when the Orfit is not present. Currently it is not understood by what amount larger
stretch-holes in the immobilization cast could reduce breast surface dose, while maintaining
requisite physical rigidity for immobilization.
It was observed during experimentation that the immobilization cast varied in thickness
due to non-uniform stretching over the phantom. This is an unavoidable aspect of using the
cast material. How this affected the results during the experiment (dose increase from the Orfit
in a given region) is not known given the complexity of both the anthropomorphic phantom
geometry and the field arrangement. It was shown that a thicker Orfit increases surface dose
where the beam is entering the phantom. It was also observed that the Orfit was not in direct
contact with the phantom surface in every region. In particular, the Orfit did not sit perfectly
on medial side of the ipsilateral breast and the midline. This could possibly be the reason why
the same cross-hatched patterning is not observed in this region. The elevation of the cast
material from the surface would allow greater scattering and dispersion of secondary photons
and electrons set in motion within the cast structure by the time it reached the phantom surface.
Under calibration irradiation conditions at the surface, MOSFETs measure dose at
70 μm WED and Gafchromic EBT film at 153 μm WED. In ideal, normally incident radiation
the MOSFETs measure a lower dose than film as a result of the different WED. Surface dose
in breast radiotherapy is by contrast much more complicated. The placements of MOSFETs
in this experiment experienced highly oblique beam angles, multiple field sizes, position
variation within large fields, and varying backscatter conditions. All MOSFETs were placed
face up on the phantom surface throughout measurements and the measurement conditions
varied from 0–360◦ angle of incidence. That is, the MOSFETs were measuring both the
contribution of entrance and exit dose to the total surface dose. Keeping the MOSFETs face
up regardless of beam orientation results in a water equivalent material thickness of 70 μm
above the measurement depth for either build-up or build-down, depending on which beam
angle is being used.
A comparison between the MOSFET- and Gafchromic EBT film-measured doses revealed
varying levels of agreement. This is due to the build-up dose gradient changing depending on
the beamÕs’ angle of incidence. As the angle of incidence increases, that is, the beam becomes
more tangential to the phantom surface, the build-up dose gradient decreases. Therefore the
differences in doses measured at 70 μm and 153 μm WED vary depending on the angle of
incidence. This is observed in the comparison between the MOSFET- and Gafchromic EBT
film-measured doses. A further complication in these comparisons arises due to the MOSFET
being a point detector and the film being a 2D detector. The small MOSFET measurement
volume makes the measured dose susceptible to the varying thicknesses of the build-up cast
material.
Two trends are evident from the results. The first is that the beam obliquity has a large
effect on the surface dose. The highest surface dose was observed where the beam was more
tangential to the surface. This is in agreement with previous studies (Dogan and Glasgow 2003,
Hsu et al 2008, Quach et al 2000). The second is that the presence of the immobilization
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cast increased the surface dose by varying amounts. The highest increase in surface dose
was observed at beam entrance locations. At tangential beam and beam exit locations the
immobilization cast had a reduced effect on the surface dose. This corresponds well to the
results presented by Hsu et al (2008). The study by Lee et al (2002) suggests that for head
and neck radiotherapy, skin reactions were caused by a combination of the use of tangential
beams, use of an immobilization cast and inclusion of the skin in the target volume. The
increases in surface dose due to the immobilization cast were on average 18%, which suggests
that the surface dose increases found in this study would contribute to an increased chance of
skin side effects.
An analysis of the variation of the surface dose with varying incident beam angle and cast
thickness reveals that even when there is no cast material above a measurement point (i.e. in
a gap in the cast), the surface dose is still increased by 35% to 60%. With cast material above
the measurement point the dose increased to up to 55% of the dose at dmax (1.5 cm), which is
similar to the result found by Hadley et al (2005) of 61%. The surface dose increased with
increasing beam obliquity and thickness of cast material (and consequently smaller gaps in
the cast). Chiu-Tsao and Chan (2010) also found with Gafchromic EBT film that the average
surface dose increased both under gaps and struts in an immobilization cast. This suggests
that to reduce the increase in surface dose due to an immobilization cast, the cast should be
stretched to be as thin as possible with as large air gaps as possible whilst still retaining enough
structural integrity to achieve immobilization.
Both MOSFET and Gafchromic EBT film were found to be suitable tools for surface
dosimetry in breast cancer treatment. The presented data demonstrates good agreement
between the two detectors within the discussed expected limitations of dose measurement in
such a complex geometry. The advantages of the MOSFET detector system are its ability
for real-time and high spatial resolution surface dosimetry, which allows quick analysis of
the contribution of individual beams and segments to the surface dose. The Gafchromic EBT
film also provided excellent spatial resolution and allowed for 2D surface dose maps to be
presented, highlighting the effect of the immobilization cast on entrance and exit surface dose.
The doses measured by each detector are useful; while EBT measures dose in a volume 40
μm thick centered at 153 μm WED, the MOSkin measures dose exactly at 70 μm WED.
Comparison of these doses can be useful clinically for determining the dose gradient near the
surface. In addition, skin toxicity can occur due to radiation damage at different depths in the
skin, such as the skin epidermis and basal layer. The use of two detectors is a step toward a
more complete prediction of radiation damage to the different components of the skin.
5. Conclusion
The use of an immobilization cast caused significant increases in surface dose to the breast
phantom as measured by two surface dose detectors. The effect of the cast depended on
whether the surface dose was entrance or exit dose, with the greatest increases in surface
doses observed in the former case. The increase in surface dose must be considered with any
clinical advantages that could be obtained by using a thermoplastic immobilization cast for
breast immobilization.
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